Metronidazole Suppository 500mg | Gynecological Anti-Anaerobic & Antitrichomonal

Metronidazole Suppository
  • Dosage: Metronidazole  500mg
  • Packaging:6 pics/ blister*2/box
  • Shelf Life: 36 months 

Click to add this item to cart.

Product Description

Product NameMetronidazole Suppository 500mg (Metronidazole Rectal Suppository)
SpecificationEach suppository contains: Metronidazole 500mg in a suitable suppository base
Dosage FormRectal Suppository (for rectal administration)
Active IngredientMetronidazole (Nitroimidazole Antimicrobial / Antiprotozoal)
Pharmacological ClassAntimicrobial / Antiprotozoal Agent (Nitroimidazole Derivative)
Route of AdministrationRectal administration. Insert deep into the rectum. Typically every 8 hours or as directed, for a specified course, as directed by a healthcare professional.
PackagingIndividually sealed suppositories (blister or foil pouch); typically 10 suppositories per box
StorageStore in a cool place (below 25°C), protected from light. Keep away from heat. Keep suppositories in their sealed packaging until use.
Shelf Life36 months (unopened, when stored as directed)

Product Overview

Metronidazole Suppository 500mg is a rectal suppository preparation containing metronidazole 500mg per suppository. Metronidazole is a nitroimidazole derivative with both antibacterial activity against anaerobic bacteria and antiprotozoal activity. The rectal suppository formulation provides systemic delivery when oral administration is not feasible.

Metronidazole Suppository 500mg: What the Published Guidance Says

The obstetric emergency medicines and newborn-care antiseptics that sit on the WHO Model List — supplied with the labelling discipline these products demand.

Metronidazole Suppository 500mg is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Maternal & Newborn range overview.

  • The protocol, and why presentation matters MSF describes two protocols: an intravenous/intramuscular schedule of 4 g by IV infusion over 15–20 minutes, then 10 g intramuscularly, then 5 g IM every four hours; and an IV-only schedule of 4 g over 15–20 minutes followed by 1 g per hour. Treatment continues for 24 hours after delivery or the last seizure. MSF Essential Drugs — Magnesium sulfate injectable
  • Monitoring and the antidote Patellar reflex, blood pressure, heart and respiratory rate are checked every 15 minutes during the first hour, then hourly, with urine output checked hourly. If signs of overdose appear, magnesium sulfate is stopped and 1 g calcium gluconate given by slow intravenous injection as the antidote. MSF also notes magnesium sulfate should not be combined with nifedipine. MSF Essential Drugs — Magnesium sulfate injectable
  • Single-dose sachets are preferred, and the container matters MSF states the 3 g single-dose sachet or tube is preferred over the 20 g tube to minimise contamination from opened tubes, and warns against combining chlorhexidine with soap or other antiseptics such as povidone-iodine. MSF UniCat — Chlorhexidine 7.1%, umbilical cord gel

These points are quoted because they shape how Metronidazole Suppository 500mg is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

Metronidazole Suppository 500mg — Supply Parameters

Product NameMetronidazole Suppository 500mg (Metronidazole Rectal Suppository)
SpecificationEach suppository contains: Metronidazole 500mg in a suitable suppository base
Dosage FormRectal Suppository (for rectal administration)
Active IngredientMetronidazole (Nitroimidazole Antimicrobial / Antiprotozoal)
Pharmacological ClassAntimicrobial / Antiprotozoal Agent (Nitroimidazole Derivative)
Route of AdministrationRectal administration. Insert deep into the rectum. Typically every 8 hours or as directed, for a specified course, as directed by a healthcare professional.
StorageStore in a cool place (below 25°C), protected from light. Keep away from heat. Keep suppositories in their sealed packaging until use.
Therapeutic groupMaternal & Newborn — Maternal & Newborn
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Chlorhexidine Acetate Suppository 20mg, Erythromycin Suppositories 100mg, Martrine Suppository 50mg, Progesterone Suppository 25mg, Clotrimazole Vaginal Suppositories 150mg, hCG Injection 5000 IU, Magnesium Sulphate BP 10% 10mL.

Quality Control, Pharmacopoeial Standards & Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Metronidazole Suppository 500mg is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

A typical release panel for this presentation covers:

  • Testing for description and identification
  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)
  • Testing for uniformity of dosage units
  • Testing for water content and pH where applicable

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packaging, Labelling & Export

  • Pack size: Individually sealed suppositories (blister or foil pouch); typically 10 suppositories per box. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store in a cool place (below 25°C), protected from light. Keep away from heat. Keep suppositories in their sealed packaging until use..
  • Shelf life: 36 months (unopened, when stored as directed). Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Registration, Dossier & Tender Support

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation, stability protocol and the shelf-life justification for the marketed pack.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.

This page describes Metronidazole Suppository 500mg as a product of the obstetric and newborn-care medicines named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.

Frequently Asked Questions

What pack size is available for Metronidazole Suppository 500mg?

The reference pack is Individually sealed suppositories (blister or foil pouch); typically 10 suppositories per box. Non-standard blister, bottle and carton configurations are quoted against your artwork, matched to the stability data already held for the presentation.

What documentation comes with a shipment of Metronidazole Suppository 500mg?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.

Does the batch documentation for Metronidazole Suppository 500mg support a registration filing?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Do you supply magnesium sulfate in the strengths used in obstetric protocols?

Yes. We supply magnesium sulfate injection and will mark the ampoule strength prominently, because MSF explicitly warns users to check the ampoule strength before use.

Can you supply chlorhexidine for umbilical cord care?

Yes — chlorhexidine 7.1% digluconate delivering 4% chlorhexidine, the concentration and indication carried in section 22.7 of the WHO Model List.

Related Maternal & Newborn Products

Browse the full Maternal & Newborn range; all Suppositories; the complete product catalogue.

Request a Quotation for Metronidazole Suppository 500mg

Send the specification, pack size, quantity and destination market for Metronidazole Suppository 500mg 500mg and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products